astrazeneca - Search News

News

AstraZeneca Stock Rises

AstraZeneca Profit, Revenue Lifted by Cancer Drugs

AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer medicines.

Investopedia on MSN · 11h

AstraZeneca Stock Rises as US, Cancer Drugs Growth Lifts Q2 Results

AstraZeneca shares are rising in premarket trading Tuesday after the pharma giant beat second-quarter estimates on strong U.S. growth and demand for its cancer drugs.

Reuters on MSN · 17h

AstraZeneca beats profit expectations on robust drug sales, U.S. demand

AstraZeneca beat second-quarter profit forecasts on robust sales of cancer, heart and kidney disease drugs and strong demand in the U.S., where it has invested $50 billion to expand amid tariff threats from President Donald Trump.

AstraZeneca beats forecasts

The Wall Street Journal on MSN · 13h

AstraZeneca Books Record Quarterly Revenue as U.S, Oncology Boosts Growth

The pharmaceutical giant said second-quarter revenue increased to $14.46 billion from $12.94 billion. U.S. revenue was up 13%.

The Financial Times · 17h

AstraZeneca beats forecasts after record US growth

AstraZeneca’s revenues beat expectations for the second quarter, powered by record growth in its all-important US business. The UK’s biggest pharmaceutical company said sales in the US were up 14 per cent in the quarter from a year earlier,

Free Malaysia Today on MSN · 16h

AstraZeneca’s quarterly net profit jumps on record US growth

The US, a critical market for the pharmaceutical industry, accounted for 44% of AstraZeneca’s total revenue in the second quarter, with US revenue jumping a record 13%. The comp

AstraZeneca increasing focus on US market, as it is 'first to provide access to patients': CFO

AstraZeneca CFO Aradhana Sarin tells Yahoo Finance the company sees US innovation threatened by China, even as it commits $50 billion in manufacturing.

Fierce Biotech16h

AstraZeneca drops lead T-cell receptor therapy from $200M Neogene buy

AstraZeneca has dropped the lead candidate from its $200 million buyout of Neogene Therapeutics as part of a wider cell ...

18hon MSN

AstraZeneca beats second-quarter profit expectations, maintains outlook

AstraZeneca beat second-quarter earnings expectations on Tuesday, helped by strong sales of key cancer, heart and kidney ...

17h

AstraZeneca share price forecast after earnings

AstraZeneca share price held steady this week after the company published strong financial results on Tuesday.

BioSpace8h

AstraZeneca CEO Says World ‘Needs to Share’ in Global Pharma R&D

Pascal Soriot's comments came during AstraZeneca's Q2 earnings call in regard to President Donald Trump’s newly announced ...

9hon MSN

AstraZeneca seeks US drug price cuts amid expansion plans, strong demand

AstraZeneca has proposed price cuts to its drugs in the United States, its CEO said on Tuesday, days after unveiling a $50 ...

4hon MSN

Why AstraZeneca Stock Was Topping the Market on Tuesday

Investors were clearly impressed by the company's second-quarter beats, especially the one on the bottom line.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results